55 related articles for article (PubMed ID: 12210501)
1. Blocking the translation elongation factor-1 delta with its antisense mRNA results in a significant reversal of its oncogenic potential.
Lei YX; Chen JK; Wu ZL
Teratog Carcinog Mutagen; 2002; 22(5):377-83. PubMed ID: 12210501
[TBL] [Abstract][Full Text] [Related]
2. Antisense inhibition of translation initiation factor 3 reverses its oncogenic potential.
Lei YX; Joseph P; Ong TM
Teratog Carcinog Mutagen; 2002; 22(6):403-9. PubMed ID: 12395402
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene.
Joseph P; Lei YX; Whong WZ; Ong TM
J Biol Chem; 2002 Feb; 277(8):6131-6. PubMed ID: 11711542
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene.
Joseph P; Lei YX; Whong WZ; Ong TM
Cancer Res; 2002 Feb; 62(3):703-7. PubMed ID: 11830523
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of expression of translation factors--a novel molecular mechanism for cadmium carcinogenesis.
Joseph P; Lei YX; Ong TM
Mol Cell Biochem; 2004 Jan; 255(1-2):93-101. PubMed ID: 14971650
[TBL] [Abstract][Full Text] [Related]
6. [Antisense TIF3 reverses the oncogenic potential of CdCl2-transformed BALB/c-3T3 cells].
Lei Y; Pius J; Wu Z; Ong TM
Wei Sheng Yan Jiu; 2002 Aug; 31(4):255-7. PubMed ID: 12600033
[TBL] [Abstract][Full Text] [Related]
7. Modulation of elongation factor-1 delta (EF-1 delta) expression by oncogenes in human epithelial cells.
Kolettas E; Lymboura M; Khazaie K; Luqmani Y
Anticancer Res; 1998; 18(1A):385-92. PubMed ID: 9568107
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transforming growth factor beta (TGFbeta1) expression and extracellular matrix secretion in human peritoneal mesothelial cells by pcDU6 vector-mediated TGFbeta1 shRNA and by pcDNA3.1(-)-mediated antisense TGFbeta1 RNA.
Liu F; Liu H; Peng Y; Yuan F; Liu Y; Duan S
Adv Perit Dial; 2005; 21():41-52. PubMed ID: 16686283
[TBL] [Abstract][Full Text] [Related]
9. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
10. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
11. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
12. Translational upregulation of yes accompanies eIF4E-mediated oncogenic transformation.
Defatta RJ; De Benedetti A
Int J Oncol; 2003 Dec; 23(6):1709-13. PubMed ID: 14612945
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
14. Spindlin1, a novel nuclear protein with a role in the transformation of NIH3T3 cells.
Gao Y; Yue W; Zhang P; Li L; Xie X; Yuan H; Chen L; Liu D; Yan F; Pei X
Biochem Biophys Res Commun; 2005 Sep; 335(2):343-50. PubMed ID: 16098913
[TBL] [Abstract][Full Text] [Related]
15. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
16. [Human antisense-vascular endothelial growth factor gene therapy for laryngeal tumor by cationic liposome-mediated transfection].
Deng ZH; Jin M; Huang WG; Qiu JH; Liu SL; Wang JL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):8-12. PubMed ID: 15127560
[TBL] [Abstract][Full Text] [Related]
17. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of eukaryotic translation factors in malignant transformed human bronchial epithelial cells induced by crystalline nickel sulfide.
Lei YX; Chen XM; Wu GR; Chen JK
Biomed Environ Sci; 2006 Feb; 19(1):53-60. PubMed ID: 16673819
[TBL] [Abstract][Full Text] [Related]
19. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
20. [Studies on inhibition of activated oncogene expression by antisense RNA].
Yang Q; Sun B; Chen Y; Dong Y; Chen D
Yi Chuan Xue Bao; 1996; 23(3):243-8. PubMed ID: 8950853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
